4.6.2018

Keensight Capital – Acquisition of Biovian

We acted as advisor to Keensight Capital in its acquisition of a majority stake in Biovian Oy alongside the founders and the managers of Biovian and Edmond de Rothschild Equity Strategies (ERES) funds. Our Private Equity, Tax & Structuring, and Banking & Finance services advised Keensight Capital on all relevant legal, tax, structuring and financing aspects of the transaction.

Founded in 2003, Biovian is a leading European GMP (Good Manufacturing Practice) contract development and manufacturing organisation (CDmO) of biopharmaceuticals, providing manufacturing and development services from early stage to finished product. The company provides services to approximately 30 customers, including international biotech and biopharma companies from the E.U., U.S. and South Korea.

Keensight Capital is one of the leading European growth buyout firms, having almost 20 years of experience in investing for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million. Keensight Capital has strong expertise in the sectors of internet & information technology and healthcare & wellbeing, and in particular the pharma industry and the CDmO sector.

Latest references

We advised Cibus Real Estate AB (publ) on its acquisition of three newly built retail properties in Pori, Finland.  Kesko is the tenant in all three properties, and the average lease term is 8.1 years. Cibus is a real estate company listed on Nasdaq Stockholm Mid Cap. The company’s business concept is to acquire, develop and manage properties in Europe with daily goods chains as anchor tenants. The company currently owns approximately 700 properties in Europe.
Case published 12.11.2026
We advised Seaya Nova and Molten Ventures as Finnish counsel in connection with the USD 80 million Series C financing of Pliant, a Berlin-based fintech specialising in B2B payment solutions and corporate credit cards. The financing round was led by Seaya Nova and Speedinvest, with participation from Illuminate Financial, Motive Partners, Molten Ventures and Citi Ventures. Founded in Berlin in 2020, Pliant provides modular payment solutions for businesses and holds an EU e-money licence in Finland as well as a licence from the UK Financial Conduct Authority. We advised on the Finnish law aspects of the transaction alongside YPOG, which acted as lead counsel to Seaya Nova and Molten Ventures.
Case published 12.11.2026
We advised Nala Renewables on the Finnish law aspects of the development, acquisition and financing of its battery energy storage system (BESS) project in Vuolijoki, Finland. The project comprises a 125 MW / 250 MWh battery energy storage system. Our advice extended beyond financing to the transaction’s legal due diligence and the acquisition of the project company. We also advised on key project contracts and financing documentation for the project finance facilities provided by Coöperatieve Rabobank U.A. The project is part of Nala Renewables’ growing portfolio of battery storage assets in Finland and the wider Nordic region, supporting the integration of renewable energy and contributing to the flexibility and stability of the Finnish electricity grid.
Case published 3.11.2026
We advised Foundation Clinic in connection with its funding round backed by a group of prominent Finnish technology entrepreneurs and investors, including founders behind Supercell and Wolt. Foundation Clinic is a Finnish healthcare company developing a new approach to private healthcare focused on preventive, data-driven and continuous care. The company aims to combine comprehensive health data with ongoing medical care to identify and address health risks at an early stage.
Case published 29.10.2026